Sun Pharmaceutical Industries Ltd.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Generic Drugs
    • Vaccines
  • Digital Health
    • Disease Management

Other Names/Subsidiaries

  • Able Laboratories
  • Aditya Acquisition Company
  • Antibe Therapeutics
  • Biosintez
  • Caraco Pharmaceutical Laboratories
  • Concert Pharmaceuticals
  • DUSA Pharmaceuticals
  • InSite Vision
  • Milmet Labs
  • Ocular Technologies
  • Phlox Pharma
  • Pharmalucence
  • Pola Pharma
  • Ranbaxy Laboratories
  • Solus Care
  • Sun Ophthalmics
  • Sun Pharma
  • Taro Pharmaceutical Industries.
See more in Biomedtracker

Latest on Sun Pharmaceutical Industries Ltd.

Scrip

Mounjaro In India: Price Differential, Window Of Opportunity

 
• By Anju Ghangurde

Eli Lilly’s blockbuster obesity and type 2 diabetes therapy, Mounjaro (tirzepatide) has made its India debut throwing down the gauntlet to rival Novo Nordisk, currently in the wings with Wegovy (injec

Generics Bulletin

First Xarelto Generics Waved Through In The US: When Will They Launch?

 
• By Dean Rudge

Lupin and Sun Pharma’s Taro have received the first US Food and Drug Administration approvals for a generic version of Johnson & Johnson/Bayer’s blockbuster blood thinner Xarelto (rivaroxaban) – a

Scrip

Sun Sets Up For PD-L1 Play With Checkpoint Acquisition

 
• By Anju Ghangurde

India’s top-ranked drug maker Sun Pharmaceutical Industries has signaled growing ambitions in the oncology-dermatological segment, snapping up the US immunotherapy and targeted oncology company Checkp

Scrip

India Pharma Chiefs On Future Manufacturing Networks And Specter Of Tariffs

 
• By Anju Ghangurde

US President Donald Trump’s stance on reciprocal tariffs and policy efforts towards reshoring continue to make countries nervous and CEOs of India Pharma Inc, at a recent event, weighed in, signalli